ERpred
ERpred predicts subtype-specific antagonists targeting estrogen receptors alpha (ERα) and beta (ERβ) to support identification of selective estrogen receptor modulators.
Key Features:
- CSAR data source: Built from a classification structure-activity relationship (CSAR) study using ChEMBL datasets initially comprising 11,618 compounds for ERα and 7,810 compounds for ERβ.
- Bioactivity unit and curation: IC50 was used as the bioactivity unit and curation yielded final datasets of 1,593 compounds for ERα and 1,281 compounds for ERβ.
- Machine learning algorithm: Random forest (RF) models were trained for subtype-specific classification.
- Molecular descriptors: Multiple fingerprint types were evaluated and the PubChem fingerprint demonstrated superior robustness.
- Performance metrics: PubChem-fingerprint RF models achieved accuracies of 94.65% for ERα and 92.25% for ERβ, with Matthews correlation coefficients reported as 89% for ERα and 76% for ERβ.
- Feature interpretation: Feature importance analysis highlighted aromatic rings, nitrogen-containing functional groups, and aliphatic hydrocarbons as influential for bioactivity.
Scientific Applications:
- Subtype-specific antagonist prediction: Predicts compound bioactivity specifically against ERα and ERβ.
- Selective modulator design: Guides design of selective estrogen receptor modulators (SERMs) with ER subtype specificity.
- Oncology drug discovery: Supports identification of compounds relevant to breast and endometrial cancer research related to ER signaling.
- Adverse-effect assessment: Assists evaluation of subtype specificity to mitigate risks associated with estradiol and hormone replacement therapies, including thromboembolic and cancer-related risks.
Methodology:
Conducted a CSAR study using ChEMBL datasets (initially 11,618 ERα and 7,810 ERβ compounds) with IC50 as the bioactivity unit, curated to final sets (1,593 ERα; 1,281 ERβ), trained random forest models on molecular fingerprints (PubChem fingerprint selected), evaluated performance by accuracy and MCC, and performed feature importance analysis identifying key chemical moieties.
Topics
Details
- License:
- GPL-3.0
- Cost:
- Free of charge
- Tool Type:
- web application
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- R
- Added:
- 11/27/2021
- Last Updated:
- 11/27/2021
Operations
Publications
Schaduangrat N, Malik AA, Nantasenamat C. ERpred: a web server for the prediction of subtype-specific estrogen receptor antagonists. PeerJ. 2021;9:e11716. doi:10.7717/peerj.11716. PMID:34285834. PMCID:PMC8274494.